|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/196 | |
| A61K 31/506 | |||
| A61K 45/06 | |||
| A61P 35/02 |
| (11) | Number of the document | 2240172 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08864891.0 |
| Date of filing the European patent application | 2008-12-18 | |
| (97) | Date of publication of the European application | 2010-10-20 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/087336 |
| Date | 2008-12-18 |
| (87) | Number | WO 2009/082662 |
| Date | 2009-07-02 |
| (30) | Number | Date | Country code |
| 15704 | 2007-12-21 | US |
| (72) |
ALOYZ, Raquel Silvia, CA
PANASCI, Lawrence Carl, CA
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION OF NILOTINIB AND CHLORAMBUCIL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| COMBINATION OF NILOTINIB AND CHLORAMBUCIL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA |